- Home
- Membership
- Events
- Press Office & News
- Working in NM
- Resources
- Radioisotope Supply
UKRG Guidelines - Guidance notes |
UKRG Guidelines - guidance notes
In order to manage the workload in the Radiopharmacy, it is important to establish the capacity of the unit. UKRG Capacity Planning Guidance is available to download below: UKRG_Capacity_Planning_Guidance_Sep18.pdf Please read the guidance document "Key Performance Indicators (KPIs) in Radiopharmacy" PDF DocumentPlease read the guidance document "The Responsibilities of Chief Pharmacists for the Purchase, Receipt, Storage, Supply and Disposal of Radiopharmaceuticals" PDFPlease read the guidance document "Addendum to Safe Drawing up document for 223Ra Radium" PDFPlease read the guidance document "Guidance for Introduction of a 68Ge/68Ga Generator and Labelling Service into Routine Clinical Practice" PDFUK Radiopharmacy Group pdfLinkUK Radiopharmacy Group on behalf of BNMS Link pdfJoint working party of the UK Radiopharmacy Group and NHS Pharmaceutical Quality Assurance Committee Link pdf(amended Nov-16) Guidelines for the Provision of Radiopharmacy Services in the UK A report has been published by Nuclear Medicine Communications on guidelines for the provision of radiopharmacy support to nuclear medicine. Updated March 2017 link hereThe Chief Pharmacists document has also been approved by the national NHS Pharmaceutical QA committee. UK Radiopharmacy Group and NHS Pharmacy QA Committee link pdfAdvice for Nuclear Medicine Departments following discontinuation of licensed radiopharmaceuticals and kits from the home market. The discontinued products paper has been produced as a result of the BNMS summit meeting in February 2009 and has been given the approval of the MHRA by Graham Matthew who was also present at the summit. UK Radiopharmacy Group link pdfAbstract This document is intended to reflect best practice for the radiolabelling of blood components in the UK, and is offered to the Nuclear Medicine community as a reference source based on opinions and experience from senior practitionrs of radiopharmacy. Very little evidence-based information exists on the subject, and thus the guidance represents current agreed practice in the field. link pdf |
26/02/2019 » 26/03/2019
Understanding & Implementing IR(ME)R